EXACT SCIENCES CORP's ticker is and the CUSIP is 30063PAC9. A total of 60 filers reported holding EXACT SCIENCES CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $25,851,424 | -40.4% | 25,143,000 | -48.8% | 0.57% | -43.7% |
| Q1 2023 | $43,397,465 | +11.9% | 49,143,000 | -0.1% | 1.02% | +31.2% |
| Q4 2022 | $38,788,451 | +10.3% | 49,174,000 | -10.9% | 0.78% | +27.0% |
| Q3 2022 | $35,173,000 | +10.3% | 55,174,000 | +19.8% | 0.61% | +7.0% |
| Q2 2022 | $31,883,000 | +171.5% | 46,074,000 | +280.8% | 0.57% | +181.3% |
| Q4 2021 | $11,743,000 | -63.8% | 12,099,000 | -59.8% | 0.20% | -66.3% |
| Q3 2021 | $32,464,000 | -51.4% | 30,099,000 | -44.1% | 0.60% | -55.0% |
| Q2 2021 | $66,778,000 | -59.7% | 53,799,000 | -58.0% | 1.34% | -58.4% |
| Q1 2021 | $165,752,000 | -32.0% | 127,994,000 | -31.4% | 3.23% | -47.6% |
| Q4 2020 | $243,612,000 | +25.5% | 186,534,000 | +4.5% | 6.16% | -23.0% |
| Q3 2020 | $194,095,000 | +57.1% | 178,534,000 | +38.8% | 8.00% | +26.7% |
| Q2 2020 | $123,537,000 | +158.6% | 128,584,000 | +112.5% | 6.31% | +56.6% |
| Q1 2020 | $47,768,000 | – | 60,500,000 | – | 4.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 178,534,000 | $194,095,000 | 8.00% |
| LINDEN ADVISORS LP | 292,990,000 | $318,182,000 | 3.84% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,475,000 | $48,022,000 | 1.54% |
| Cheyne Capital Management (UK) LLP | 2,350,000 | $2,546,000 | 1.26% |
| DeepCurrents Investment Group LLC | 28,948,000 | $31,403,000 | 1.06% |
| Nicholas Investment Partners, LP | 6,965,000 | $7,521,000 | 0.81% |
| Lombard Odier Asset Management (Europe) Ltd | 11,518,000 | $12,499,000 | 0.74% |
| AQR Arbitrage LLC | 18,300,000 | $19,851,000 | 0.72% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,648,000 | $30,001,000 | 0.66% |
| BlueCrest Capital Management Ltd | 16,086,000 | $17,424,000 | 0.64% |